Several other research analysts have also recently commented on KDP. Morgan Stanley set a €37.50 ($43.60) price target on Deutsche Post and gave the company a buy rating in a research report on Thursday, April 11th. Zacks Investment Research cut CGI from a buy rating to a hold rating in a research report on Wednesday, June 19th. Barclays reaffirmed a hold rating and issued a $52.00 price objective on shares of Biohaven Pharmaceutical in a research report on Tuesday, March 19th. Finally, BMO Capital Markets raised Bank of America from a market perform rating to an outperform rating and set a $37.00 price objective for the company in a research report on Monday, June 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of $29.54.
Shares of NYSE KDP opened at $28.73 on Thursday. The company’s 50 day moving average is $29.16. Keurig Dr Pepper has a 52 week low of $22.19 and a 52 week high of $31.06. The company has a quick ratio of 0.23, a current ratio of 0.32 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $40.41 billion, a PE ratio of 27.63, a PEG ratio of 1.54 and a beta of 0.46.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 19th. Stockholders of record on Friday, July 5th will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Wednesday, July 3rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.09%. Keurig Dr Pepper’s dividend payout ratio (DPR) is currently 57.69%.
In other news, Director Robert S. Singer bought 3,000 shares of the stock in a transaction dated Thursday, May 16th. The shares were bought at an average price of $28.93 per share, for a total transaction of $86,790.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Holdings B.V. Maple sold 52,902,300 shares of the stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $27.77, for a total value of $1,469,096,871.00. The disclosure for this sale can be found here. 0.44% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc increased its stake in Keurig Dr Pepper by 751.3% during the 1st quarter. Versant Capital Management Inc now owns 1,328 shares of the company’s stock worth $37,000 after acquiring an additional 1,172 shares during the period. Penserra Capital Management LLC bought a new position in Keurig Dr Pepper during the 1st quarter worth $40,000. Trust Co. of Vermont increased its stake in Keurig Dr Pepper by 177.8% during the 1st quarter. Trust Co. of Vermont now owns 1,500 shares of the company’s stock worth $42,000 after acquiring an additional 960 shares during the period. CENTRAL TRUST Co increased its stake in Keurig Dr Pepper by 3,634.0% during the 1st quarter. CENTRAL TRUST Co now owns 1,755 shares of the company’s stock worth $49,000 after acquiring an additional 1,708 shares during the period. Finally, Parallel Advisors LLC increased its stake in Keurig Dr Pepper by 30.8% during the 1st quarter. Parallel Advisors LLC now owns 2,317 shares of the company’s stock worth $65,000 after acquiring an additional 546 shares during the period. Institutional investors own 14.27% of the company’s stock.
About Keurig Dr Pepper
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
See Also: Quiet Period Expirations Explained
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.